Insurers require detailed medical justification, and your doctor is the one who can provide it
Tirzepatide Weight Loss Results The SURMOUNT trials demonstrated stronger outcomes
Discontinuation rates due to adverse effects remain relatively low, with approximately 6% of Zepbound users and 8% of Wegovy users stopping treatment ^2
We urge you to take a look at The Purser Method and Homocysteine Inflammatory Genes to get a full understanding of what we have to offer in terms of consultation, genetic testing, intracellular deficiencies, and so much more
For this reason, individuals with a personal or family history of MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) should not use these therapies
For private insurance, we recommend contacting your benefits administrator with your details and the Drug Identification Number (DIN) and the drug name to determine your coverage.